SLN
Silence Therapeutics plc
NASDAQ · Healthcare · Biotechnology · GB
$14.59
−1.35%Leverage
- Debt / equity
- 0.00x
- Net debt / equity
- -1.87x
- Debt / assets
- 0.00x
- Debt / EBITDA
- -0.00x
- Net debt / EBITDA
- 1.19x
Liquidity & coverage
- Current ratio
- 7.42x
- Quick ratio
- 7.42x
- Cash ratio
- 5.67x
- Interest coverage
- —
- EBITDA / interest
- —
- Working capital
- $81.6M
Cash & dividend
- FCF / debt
- -378.08x
- Cash flow / debt
- -377.56x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Jun 1, 2026